On one hand, increased expression of neutrophil (and mast cells)-derived IL-17 is a common signature of advanced liver fibrosis, which upregulates the expression of TGF-β receptor in HSCs and promotes liver fibrosis, and blocking IL-17/IL-22 alleviates liver fibrosis (80). This evidence concerns the gene IL22 and Hepatic fibrosis.